Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib + Dexamethasone in Relapsed/Refractory Multiple Myeloma
NCT00389701Phase 2Unknown
- Sponsor
- Sparrow Regional Cancer Center
- Start
- Mar 2006
- Primary completion
- Dec 2009
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in multiple myeloma (MM), sponsored by Sparrow Regional Cancer Center. Status: unknown.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00389701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00389701.